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Abstract

Nitric oxide (NO) is inactivated in the human body when
exposed to superoxide (02 -;. This reaction forms peroxynitrite
(ONOO). Superoxide is produced in the cardiac system by
several mechanisms, including NAD(P)H oxidase. Superoxide
dismutase (SOD) breaks down superoxide into oxygen and
hydrogen peroxide. This prevents superoxide from reacting
with nitric oxide and allows norma/function to take place.
Superoxide and peroxynitrite are main contributors to vascular
disease in the human bod); in particular hypertension.
Experiments have shown that there is an increase of superoxide
production in spontaneously hypertensive rats (SHR) vs. agematched Wistar Kyoto rats (WKY) that were normotensive. The
increase in superoxide production intensifies in the presence of
scavenger DETCA Cu 2 +!Zn2 +. A mathematical model has been
developed by Kavdia and Popel to calculate concentrations
of NO, ONOO·, and 0 2 - in the arterial and venule pair. Using
this model we calculated the arterial and venule NO, ONOO-,
and 02- concentration profiles for normotension, hypertension,
SOD inactivation, and NAD(P)H stimulated cases, and
analyzed which specific regions showed amplification or
reductions in concentrations. The inactivation of SOD allowed
02- concentration to significantly increase by I 0-fold under
basal conditions in hypertensive mice, while reducing the NO
concentration in the model. Basilar arteries from hypertensive
rats showed an increase of 4.1-fold in Nox4 compared to
normotensive rats. The results suggest that the increase in
superoxide in hypertensive rats is in correlation with the
increase of NAD( P)H oxidase in these rats. The trends in
superoxide production in this paper can help researchers and
the medical community understand lz)pertension and vascular
disease more thoroughly. Further, for future research, observed
increases of Noxl and Nox4 expression suggest specific regions
where 0 2 - will be high and which need to be evaluated.
Introduction
Cardiovascular disease is the leading cause of death in the
United States. According to the American Heart Association.
this disease was responsible for taking over 870.000 lives in
2005. Increased vascular production of reactive oxygen species
(ROS) is a common characteristic of cardiovascular disease 5 .
There are several factors that increase the risk of cardiovascular
disease including hypertension, hypercholesterolemia, and
6 • In the United States,
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approximately 58 million Americans.
Vascular and cardiac tissues are rich sources of ROS,
including superoxide (0 2·), hydrogen peroxide (H,O,), and
peroxynitrite (ON00-) 7. Reactive oxygen species "ar~ the
by-products of oxygen metabolism and are nonnally present
in low levels of concentration inside the cells8• ROS are
needed in aiding the signaling processes within the cells, and
also in regulating vascular smooth muscle cell contraction
and relaxation. Increasing amounts of 0 2- is the most
common trend in vascular diseases, such as hypertension,
because it causes oxidative stress in the vascular tissue9.
One of the mechanisms for controlling oxidative stress in
the vascular system is superoxide dismutase. Superoxide
dismutase consumes 0 2-, and then converts it into less harmful
compounds 10 •
The major sources of vascular superoxide include xanthine
oxidase, nitric oxide synthases, mitochondrial oxidases,
or NAD(P)H oxidases 11 • Each of these sources generates
superoxide in a different mannerism in the human body.
Xanthine oxidase (XO) is an iron sulfur flavoprotein
that is found in high concentrations in the endothelial cells
and plasma, but not in smooth muscle cellsl2. Xanthine
generates the superoxide by catalyzing hypoanthine and
xanthine to fonn uric acid. Nitric oxidase synthases (NOS),
found predominantly in the endothelial cell region, play a
major role in vascular diseases. Endothelial nitric oxidase
synthases (eNOS) require tetrahydrobiopterin (BH-l) for the
transfer of electrons to the nitrone of the L-arginine 12. This
reaction under nonnal conditions fonns nitric oxide in the
vessels. However, when BH~ is not present, eNOS generates
0 2- and Hz0 2. Mitochondrial oxidases utilize the uncoupling of
oxygen during mitochondrial oxidative phosphorylation, which
occurs during the production of ATP, to synthesize o,-. The
superoxide produced with lesion development in the arteries
comes primarily from the mitochondrial oxidasel2.
In particular, in the work reported here, we analyzed
more closely the NAD(P)H oxidase as a source of vascular
superoxide. NAD(P)H oxidases are present in endothelial cells,
fibroblasts, smooth muscle cells, neutrophils, and phagocytic
mononuclear cells 2. The study of NAD(P)H started at the
biochemical reaction of the compound in the cardiovascular
system. NAD(P)H is a multi-subunit enzyme that catalyzes O,production by reducing oxygen by one electron and using theNAD(P)H as the electron donor7 .
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In addition, nitric oxide released by
endothelial cells is a key chemical that
Figure l. Data Results from Paravinici
regulates blood flow. In oxidative stress
conditions the availability of nitric oxides
Methods
is reduced in vascular tissues, a process which is known as
endothelial cell dysfunction 10. With this dysfunction comes
Model Geometry
the natural response of the human body to overcome this
A previous model by Kavdia and Popel was used to
production of superoxide. Superoxide is neutralized by a group
simulate arteriole/venule during microcirculation. This
of antioxidant enzymes. These enzymes include SOD, CAT,
model contains six different regions in the vessels: red blood
GPx. and thiol-disulfide oxidoreductases 12 •
cell rich (CR), red blood cell free (CF), endothelium (E),
The research described here dealt primarily with
interstitial space (IS), smooth muscle (SM), and a nonperfused
SOD as the main antioxidant enzyme. There are at least
parenchymal tissue (NPT). The parenchymal tissue (PT) is the
three distinctive isoforms of SOD identified in humans:
region around the arteriole and venule pair. Figure 2 shows
mitochondrial manganese-containing SOD (MnSOD, SOD2),
the arterial and venule vessel next to each other. The regions
the cytosolic copper/zinc-containing SOD (CuZnSOD, SODl)
have increasing diameters for each separate layer. Nitric Oxide
and the extracellular SOD (eSOD, SOD3) 13 . SOD dismutases
(NO) is produced at the luminal and abluminal surfaces of the
superoxide to form hydrogen peroxide and oxygen. Loss of
endothelium 10.
endothelial NO available to endothelial cells is caused by
The steady-state mass transport equation (cylindrical
the reaction with o,-. This reaction forms ONOO-, which is
conditions) can be used to solve for the NO mass transport
a key component i; many cardiovascular diseases such as
because the convective transport of NO can be neglected and
hypertension, diabetes, and atherosclerosis. Understanding
the NO profiles reach steady state within milliseconds 10 •
the levels of nitric oxide, superoxide, and peroxynitrite should
contribute to a better understanding of the diseases and the
2
(2)
D J V C.J - L..J R ],1. 0
oxidative stress state of the vascular system.
In 2004, Kavdia and Popel developed a mathematical
In this equation, j represents the particular model of
model to create the concentration profiles for NO, ONOO-, and
interest; Cj is the concentration; Dj is the diffusivity; and Rj.i
1
0,- for an arterial and venule pair during microcirculation .
stands for the production and consumption of the species due
This model defines the geometry of the arterial and venule
to chemical reactions.
vessels parallel to each other, while using diffusion rates and
chemical reaction rates to calculate the concentration profiles.
The objective of this study was to predict NO, ONOO-,
and 0,- concentration profiles for three different cases: 1) basal
Arteriole
Venule
conditions compared to NAD(P)H stimulated conditions (2)
basal conditions in normotensive and hypertensive rats with
inactivation of SOD by DETCA (3) NAD(P)H stimulation
in normotensive and hypertensive rats with inactivation of
SOD by DETCA. We used data from Tamara Paravicini's
"Increased NADPH-Oxidase Activity and Nox4 Expression
during Chronic Hypertension is Associated with Enhanced
Cerebral Vasodilatation to NADPH In Vivo"_ In their work,
the arteries from Wistar-Kyoto rats (\VKY) were compared to
spontaneously hypertensive rats (SHR). The 0 2· production in
these arteries was measured by 5 Jtmol!L lucigenin-enhanced
chemiluminescence under various conditions. The results from
Paravicini's experiment are displayed in Figure I. The trends in
Figure :Z: Arterial/Venule Geometry
these data were applied to the Kavdia and Popel model for the
Reference 10 (Kavdia M. A computational model for free radicals transport
purpose of the current research.
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Boundary Conditions
Specific boundary conditions needed to be set to model
this geometry and diffusion rates. At the outer edge of the PT,
a zero-flux boundary condition was fixed, and at the interfaces
with the endothelium, the release of NO and 0 2 - were given by
the following equations respectively 10 •

(3)

i
acj. en
Q = Dac.
-1-'c_ _ D
J

J

ar

J

ar

(4)

The NO and 0 2- concentration profiles in the vascular tissue
were obtained from these equations.

arteriole. The arteriole is 25 Jim and the venule is 50 Jill in
diameter. This ratio was assumed due to the reported distance
between the arteriole and venule vessels 15 . The diffusivity
rates of NO, 0 2-, and peroxynitrite were assumed to be
constant across the geometry and equa\3.3 x JO·S, 2.8 x 10·5 ,
and 2.6x 10·5 cm2/s respectively according to Table I. To
determine the consumption of NO in CR region, Kavdia and
Popel used a hematocrit of 0.45 in the region 1• The reaction
rate for the consumption of NO is 1,270 s· 1 in the region 9 • The
NO that is released by the capillary endothelial cell, kcap was
determined using a hematocrit of 0.3 and a capillary volume of
0.0146 cm3 for the mode\ 10 • The kcap calculated was 12.4 s· 1
for this case 16 •

Table 1. Model Parameters

('mt~

Paramet.,;r

Chemical Reactions
The chemical reactions that are involved in the different
layers of the arterial and venule are a mixture of first and
second order reactions. Each region is discussed in further
detail in Kavdia's "Venular endothelium-derived NO can affect
paired arteriole: a computational model" 14 • The areas that are
rich in red blood cells contain high levels of hemoglobin. This
hemoglobin reacts at a high rate with the NO in the region, as
seen in the following equation where kcR is the effective NO
reaction rate constant.
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In the CF region the chemical reactions are first order reactions
because the hematocrit in this region is assumed to be zero 10•
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In the remaining of the regions E, IS, and NPT the NO reaction
is a second order reaction 10 •
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Vascular smooth muscle sGC consumes the NO for the smooth
muscle region (SM) 10 • Therefore the second-order reaction is:
RNo = ks~1 C 2No

o(N)I)·

(8)
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For the capillary-perfused PT region, the endothelial cells
of the capillaries produce NO. For this region the reaction
rate must take into account the amount of nitric oxide that is
released by the capillary endothelial cell.
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Each region is different. so each individual chemical reaction
had to be considered when the model was derived.
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Parameter Values
All parameters that were defined in the previous equations
used in the model can be found in Table 1. The geometry of
the arterial and venule vessels has been discussed in previous
reports 1•by
The
venule is assumed to be
twice the size of the
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Numerical Solutions
Flex POE 3.0 software was used for modeling the
arteriolar and venular endothelial NO, 0 2-, and ONooconcentrations. Flex POE 3.0 is computer software that can be
used for modeling and solving numerical problems.

Simulations
Tamara M. Paravicini's article "Increased NADPHOxidase Activity and Nox4 Expression during Chronic
Hypertension is Associated with Enhanced Cerebral
Vasodilatation to NADPH In Vivo" demonstrated experimental
trends in the production of superoxide (0 2-) in Wistar-Kyoto
rats (WKY) and Spontaneously Hypertensive rats (SHR). This
data was assumed for a model of the human arterial/venule
microcirculation during normotension and hypertension. For
the base case we used the whole tissue superoxide production
as fraction c 0.2 of NO production and used 10 pM of SOD.
The first simulation involved an increase of o2- production
by 22-fold due to the NADPH stimulation of the arteriolar
and venule. For this case the new whole tissue superoxide
production fraction of NO production was c = 4.4 The SOD
remained at lOpM. The results of both the normotensive and
hypertensive were compared for basal and NADPH stimulated
vessels.
The second simulation compared the three different basal
conditions with a difference in the level of SOD. We used a
condition with SOD of IOpM and a superoxide production
fraction c =0.2 and compared it to the normotensive and
hypertensive basal condition with an inactivation of SOD. The
experiment used Cu2+ chelating agent diethyldithiocarbarnic
acid trihydrate (DETCA) to inactive the Cu 2+JZn 2+ SOD. We
assumed that SOD was reduced and that the level changed
from lOjtM to lJIM. In normotensive basal condition with
reduction of SOD the superoxide production fraction remained
at c =0.2. For hypertensive basal conditions the superoxide
production fraction was c =2 due to a 10-fold increase in
superoxide production.
The third simulation compared the NAD(P)H stimulated
hypertensive/normotensive vessels with the change in SOD.
With SOD of lO ;tM, the normotensive and hypertensive
vessels both had a superoxide production fraction of c 4.4,
which are 22-fold greater than the basal conditions. With
DETCA reduction of SOD to 1 pM, the normotensive vessels
had a superoxide production fraction of c 8, which was a
40-fold increase from the basal conditions. With DETCA
reduction of SOD to 1 pM, the hypertensive vessels had a
superoxide production fraction of c = 18.4, which was 2.3-fold
greater than the normotensive NADPH stimulated conditions.

=

vertical line on the graph at 0.975 ern represented the middle
of the arterial vessel. The endothelial cell region was 5 pm,
therefore the second line was hard to distinguish from the first
because it was at 0.9775 em on the graph. The third vertical
line represented the smooth muscle cell region in the arterial
vessel. The fourth vertical line represented the middle of the
venule vessel at 0.105 em on the graph.
For the base case, we used normal parameters as described
in the methods section. The plots of NO, 0 2-, and ONooconcentrations for the base case are displayed in Figures 3,
4 and 5, respectively. In Figure 3, the NO production of the
Basal hypertensive and Basal normotensive with SOD of
10 pM is the same. This simulation of basal hypertensive
and normostenive with SOD of 10 ttM had the highest NO
concentration and the lowest 0 2- concentration. The NAD(P)H
stimulated hypertensive and normotensive with SOD of lO pM
were equal to each other. The NO concentration in the lumen
of the CR region of both the arterial and venule was zero. As
the NO profile approached the EN region, the concentration
reached 100 nM. From that region, the NO concentration
profile decreased back to 0 nM in the lumen of the venule
vessel. The NAD(P)H stimulation during this case only
caused a noticeable change in the NO profile in the IYf region
surrounding the arterial and venule pair.
120

Results
Normotensive and Hypertensive Cases (Basal and NADPH
excited) with SOD of IOp!U
Profiles for the reactive oxidative species were generated
according to the concentration values along the horizontal
https://scholarworks.uark.edu/inquiry/vol9/iss1/17
center axis of the geometry, as seen in Figure 2. The first
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The ONoo- concentration profile showed a visible change
4
in Figure 4 throughout the arterial and venule pair due to
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the NAD(P)H stimulation. This stimulation caused a 20-fold
increase in the ONoo- concentration. In the SM region, the
ONoo- concentration increased from I nM to 2.5 nM due to
the NAD(P)H stimulation. The perioxynitrite concentration
was 0 nM in the lumen of the venule vessel.
The 0 2 - concentration profile is shown in Figure 5.
This concentration profile shows that there was an increase
in superoxide production in both the arterial and venule EN
region. The 0 2 - concentration had a peak at 0.433 nM and 2.29
nM in the arterial EN and venule EN, respectively.
4

- Normoten siveiHyperten sive
Basal SOD to 10uM

3.5
..._Normotensive/Hyperten sive
NADPH Stimulated SOD to
10uM

3
2.5

concentrations of the NO were 102.3 nM, 96.InM, and 89.05
nM for Normotensive/Hypertensive basal case with SOD to 10
pM, Normotensive basal case SOD to I pM, and Hypertensive
basal case with SOD to I pM, respectively in the EN arterial
regions. The hypertensive basal case with SOD to I pM shows
a NO concentration that was 20 nM less in the PT surrounding
region of the arterial/venule pair compared to normotensive
vessels in the same case.
The peroxynitrite concentration profile is shown in Figure
7. The hypertensive vessel with SOD reduction to I JIM had
the highest levels of ONoo-. This corresponds to the same
case having the lowest levels of NO. The peak in the arterial
vessel was in the EN and SM region. The concentration levels
were 6.56 nM, 4.25 nM, and 0.647 nM in hypertensive basal
case with SOD to I JIM, normotensive basal case with SOD
to I pM, and normotensive/hypertensive basal case with SOD
to 10 pM, respectively. The peaks for the venule EN and SM
region were I7.8 nM, 15.6 nM, and 2.36 nM, respectively.
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Normotensive and Hypertensive Cases (Basal Only) with
SOD being inactivated from 10 pM to 1 pM
We modeled the concentration profile of NO, ONoo-, and
02- for the basal case only of normotensive and hypertensive
cases, but the SOD was reduced from IOpM to 1 JIM with
DETCA Cu2+JZn2+. The nitric oxide production in the
reduced SOD was lower than that of the 10 JIM SOD cases.
Also the NO level for the hypertensive case with SOD of 1
JIM was much lower than the normotensive case with SOD of
lpM under basal conditions. Figure 6 shows that the highest
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The superoxide concentration profiles for these specific
cases are in Figure 8. This profile demonstrates that SOD
reduction caused an increase of superoxide in the vessels by
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10-fold in hypertensive vessels compared to the cases with
SOD of 10 11M. In the hypertensive basal case with SOD
reduced, the superoxide concentration was 1.81 nM and
13.3 nM in arterial and venule EN region, respectively. In
comparison the arterial and venule EN region of normotensive
basal with an SOD level of 1 JIM had peaks of 1.54 nM and
12.83 nM, respectively.

Finally the profile for the NO, ONoo-, and 0 2- for
normotensive and hypertensive vessels under NAD(P)H
excited conditions with SOD reduced from 10 JIM to lJIM. The
hypertensive NAD(P)H excited vessels with an SOD of 1 JIM
had the lowest concentration of nitric oxide. These results are
shown in Figure 9. The endothelial region of the arterial vessel
had the highest concentration of NO during microcirculation.
During normotensive/hypertensive vessels with NAD(P)H
stimulation and with SOD of 10 JIM, the concentration was
99.6 nM. However, when SOD is reduced to 1 JIM, the NO
concentration in normotensive was75.6 nM and in hypertensive
was 65.2 nM. The lumen of both the arterial/venule pairs was
reduced to 0 nM in all three cases.
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The ONoo- concentration profile for the NAD(P)H
cases with SOD reduction are presented in Figure 10. The
reduced SOD, hypertensive vessels had the highest ONooconcentrations. The lowest concentrations of perioxynitrite
were in the lumen of the venule. The highest concentrations
of the ONoo- were in the EN and SM region of the venule
vessel. The concentrations were 29.4 nM, 23.3 nM, and
3.45 nM for the reduced SOD hypertensive, reduced SOD
normotensive, and the 10 pM SOD normotensive/hypertensive,
respectively.
The superoxide concentration profile for the NAD(P)H
cases is shown in Figure 1 L This profile shows that. when
the SOD was reduced in the hypertensive vessels, the 0 2https://scholarworks.uark.edu/inquiry/vol9/iss1/17
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Figure 10. ONOO" CONCENTRATION PROFILE FOR CASE 3

concentration peaks in the EN and SM of both the arterial
and venule vessels. The arterial EN concentration level
was lower than that of the venule because in the arterial the
superoxide levels dropped dramatically before these regions.
In hypertensive vessels with SOD reduction, the arterial EN
superoxide concentration was 4.4 nM and in the venule EN
superoxide concentration was 17.5 nM. In normotensive
vessels with SOD reduction, the arterial EN superoxide
concentration was 2.9 nM and in the venule EN superoxide
concentration was 14.9 nM.
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Discussion

Effects of SOD Inactivation
SOD inactivation was shown to increase the superoxide
production by 10-fold in Basal Hypertensive cases. This
resulted in an increase in peroxynitrite but a decrease in the
nitric oxide. SOD reduction with NAD(P)H stimulation caused
an increase of 2.1-fold and 4.1-fold in superoxide production
in normotensive and hypertensive vessels, respectively
when compared to vessels with SOD of 10 JtM. When SOD 6
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was activated, the superoxide production was the same in
hypertensive and normotensive vessels. This shows that SOD
is very important in controlling 0 2- production and also in
vascular disease. Without SOD, the level of superoxide may
increase dramatically, potentially inducing vascular diseases
When SOD is 10 JIM, the vessels have a higher than normal
level of H 20 2 due to the dismutase of superoxide. This
explains why the levels of H 20 2 in plasma are higher than in
normotensive patients 3 • This level of H 20 2 , which is a powerful
vasodilator, may have important consequences in the vascular
system3 . Current therapies for vascular disease, such as~
blockers, angiotensin antagonists, and angiotensin-converting
enzyme inhibitors, act like antioxidants in some way' 7 . New
antioxidant therapies have the potential to be discovered to
treat hypertension.

Effects of Normotension vs. Hypertension
Spontaneous hyptertensive vessels can cause a 10-fold
increase from normotensive vessels in basal conditions and
a 2.3-fold increase from normotensive vessels in NAD(P)H
stimulated vessels. Our data show that superoxide production is
increased dramatically in hypertensive vessels. In hypertensive
basilar vessels the Nox4 was 4.1-fold higher3 • This shows that
there is a direct correlation between the increase of NAD(P)H
oxidase in regions and the increase of production with
superoxide and vasodilation. In the area directly before the EN
region, the superoxide level decreases dramatically. However,
in the endothelial region, there is a large increase in superoxide
production. This can be explained because this is where Nox4
is found to be most prevalent. Nox4 mRNA is seen to be 125
-fold higher in endothelial cells than in smooth muscle cells 2
(see Table 2).
(xHr'tiO'copies 18S)

Nox4

Noll

MGnoc)te

Undct.:ctable

0.10

Endothelial Cells

270.0

0.87

Smooth Muscle Cells

2.15

0.22

fibroblasts

6.25

0.45

Table 2. EXPRESSION OF NOX ISO FORMS

Also Nox4 and Noxl mRNA levels are 2.5-fold and 10fold greater in spontaneously hypertensive rats than in agematched Wistar Kyoto rats, respectively 18 • Published data and
the results from this model, showed a direct corrlation between
superoxide production and Nox expression.

Effects ofNAD(P)H stimulation
When NAD(P)H was used to stimulate the vessels, it
increased superoxide in the cells because the NAD(P)H
reacted with the oxygen in the vessels. During this reaction,
superoxide was produced, which significantly increased the
levels of superoxide in the vessels. NAD(P)H stimulation
increased the superoxide produce 22-fold compared to normal
basal conditions when SOD was 10 JIM. During NAD(P)H
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stimulation when SOD was reduced to 1 JtM, the superoxide
production was 40-fold higher and 92-fold higher for
normotensive and hypertensive, respectively when compared to
normal basal conditons. In human coronary arteries, NAD(PJH
stimulation is the major source of superoxide production, and
in human coronary artery disease the NAD(P)H acivity is
significantly increased 5

Importance and Conclusion
The purpose of this model was to provide additional
information about oxidative stress in hypertension. During
hypertension, there was an increase in superoxide production
when SOD was decreased. The trends from the NO, ONOO·.
and o2- concentration profile show us which regions were
affected by the disease and the physiological affects on
the walls of the arteriole and venule. In addition, the H 20 2
generated during superoxide dismutase may have a signifcant
correlation to vasodilation during hypertension. The relevance
of this research is underlined in the major role of oxidative
stress in vascular diseases. The future of cardiovascular therapy
is based on the balance between NO, ONOO-. and 0 2- within
the body 19 •

Future Work
The data from this study could be used to further the
understanding of vascular diseases. Nox 1 and Nox4 are
highest in the endothelial and smooth muscle cell region. The
NAD(P)H oxidases are also expressed more in hypertension
than during normotension. As previously stated, the expression
of Noxl is 10-fold greater and Nox4 is 2.5-fold greater. In
recent years, there have been a number of publications about
treating the arterioles and veins with different medications.
Very similar tests have been done to measure superoxide
production and Nox expression.
In one particular experiment, the vessels were treated with
different hypertension medications: I) high dose candcsartan
2) low dose of candesartan 3) a dose of a combined hyralazine
and hydrochlorothiazide 18 • All three treatments reduced
the expression of Noxl and Nox4. From the results of this
modeling study, we can hypothesize that a reduction of Nox I
and Nox4 will also reduce the superoxide levels produced in
the arterial and venule flow. The data show that the strong
correlation might suggest a stronger link between NAD(P}H
stimulation and the development of vascular diseases. In
future research, we plan to model the concentration profiles of
medically treated vessels to evaluate the effects of the medicine
on the NO, ONOO-. and 0 2- profiles.
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Mentor Letter
Mahendra Kavdia speaks highly of Aaron Strobel's academic
excellence and of the importance of the research described in
this article.
Aaron started his research in my Laboratory in April,
2007. He obtained his undergraduate degree in Biological
Engineering with a concentration in Biomedical
Engineering/PreMed May, 08. He is one of the best
students in our Department. Though the long-term plan
of Aaron is to pursue a MD degree, he had an internship
offer at St. Jude, San Francisco, CA but decided to work
in bioinformatics area at Little Rock, AR to better prepare
him for his long-term goals of pursuing MD. Aaron was
motivated to perform research. He wrote an honors
proposal and got funded in Spring, 08. He participated
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in several research internships. The proposed research
was to investigate the role of NADPH oxidase derived
oxidative stress conditions on nitric oxide metabolism.
This research is extremely important as oxidative stress
is involved in numerous pathophysiological conditions
such as cardiovascular diseases, diabetes, and aging. We
had developed a computational model to understand the
interaction of NADPH oxidase related oxidative stress
on nitric oxide levels in vascular tissue. Aaron showed
great initiative and also started communication with
an experimental researcher in Australia to support his
modeling research. His participation in my laboratory
was very valuable for his basic knowledge of Biomedical
Engineering and hands-on experience. Publication of this
article in Inquiry certainly is a worthwhile recognition for
Aaron's work and he deserves this.
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